Lv3
330 积分 2023-05-18 加入
A novel anti-HER2/EGFR bispecific antibody-drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
1天前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
4个月前
已完结
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
11个月前
已完结
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
1年前
已完结
Motixafortide: First Approval
1年前
已完结
Structural basis of Notch recognition by human γ-secretase
1年前
已完结
Structural basis of Notch recognition by human γ-secretase
1年前
已完结
Discovery of Covalent MKK4/7 Dual Inhibitor
1年前
已完结
PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies
1年前
已完结
皖公网安备34019202002308
